Processa Pharmaceuticals, Inc. Financial Ratios — PCSA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	-103.8	-146	-418.88	- -	- -	- -	-74.75	-37.91	-93.14	-47.2	-166.43	-178.52	-354.51	-372.97
Return on Assets (%)	- -	-53.11	-89.96	-165.07	-253.13	-624.75	-124.33	-48.69	-28.74	-79.86	-44.23	-156.34	-154.4	-262.87	-245.66
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	30.65	39.84	37.68	-10.98	100	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	-1,126.39	-814.9	-1,612.58	-659.76	-1,427.34	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	-1,182.84	-947.68	-2,011.85	-870.32	-1,430.52	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	34,618.14	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-1,270.06	-982.03	-3,436.72	-2,629.77	-6,743.58	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	-1,270.15	-982.05	-4,220.71	-2,957.22	-6,719.64	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	-1,441.47	-988.86	-5,622.15	-2,995.08	-7,580.8	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	11.88	0.69	28.97	1.42	11.32	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-91.46	-145	-297.55	- -	- -	- -	-74.75	-37.91	-93.14	-47.2	-166.43	-178.52	-354.51	-372.97

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	2	1	1	1	1	2	2	- -	1	- -	- -	- -	- -	- -	- -
ST Debt	- -	1	1	- -	1	2	2	- -	1	- -	- -	- -	- -	- -	- -
LT Debt	2	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	-0.52	-0.3	-0.33	-1.83	-22.59	-1.36	-0.06	-0.33	-0.06	-0.01	-0.01	-0.01	-0.01	- -
Net Debt/EBITDA	- -	-0.05	-0.23	-0.33	-1.82	-22.55	0.22	0.39	-0.04	2.71	1.53	0.33	0.41	0.1	0.4
Total Debt/EBIT	- -	-0.5	-0.26	-0.26	-1.38	-22.54	-1.36	-0.05	-0.26	-0.05	-0.01	-0.01	-0.01	-0.01	- -
Net Debt/EBIT	- -	-0.05	-0.2	-0.26	-1.38	-22.5	0.22	0.33	-0.03	2.37	1.43	0.32	0.41	0.1	0.4
EBITDA to Interest Expense	- -	-12.68	-23.21	-5.48	-3.18	-0.29	-30.49	-24.16	-85.43	-20.04	-29,767.92	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	-14.64	-23.46	-5.52	-3.18	-0.29	-30.83	-24.3	-85.43	-20.04	-29,767.92	- -	- -	- -	- -
EBIT to Interest Expense	- -	-13.31	-26.99	-6.84	-4.19	-0.29	-30.52	-28.07	-107.36	-22.9	-31,952.93	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	52.3	65.96	56.87	47.45	-1,896.86	-72,634.35	12.51	77.73	73.62	90.98	96.3	86.67	86.22	52.52	71.38
Long-Term Debt/Equity (%)	79.28	23.66	8.71	40.9	- -	- -	- -	- -	1.84	0.54	0.03	2.02	1.34	0.03	- -
Long-Term Debt/Capital (%)	41.71	16.4	5.94	27.78	- -	- -	- -	- -	1.63	0.53	0.03	1.96	1.3	0.03	- -
Long-Term Debt/Total Assets (%)	41.47	15.61	4.95	19.41	- -	- -	- -	- -	1.35	0.49	0.03	1.75	1.16	0.02	- -
Total Debt/Equity (%)	90.09	44.23	46.48	47.23	-69.05	-68.58	656.16	2.37	12.83	1.43	0.31	3.07	3.02	4.33	- -
Total Debt/Capital (%)	47.39	30.67	31.73	32.08	-223.12	-218.23	86.78	2.32	11.37	1.41	0.31	2.98	2.93	4.15	- -
Total Debt/Total Assets (%)	47.12	29.18	26.43	22.41	1,309.8	49,809.73	82.09	1.84	9.44	1.3	0.3	2.66	2.6	2.28	- -
Net Debt to Equity	-10.63	4.37	35.3	47.23	-68.95	-68.44	-106.89	-15.58	1.38	-66.5	-64.73	-87.05	-94.33	-70.24	-99.28
Net Debt/Capital (%)	-11.89	4.18	26.09	32.08	-222.02	-216.85	1,552.28	-18.45	1.33	-194.28	-181.97	-543.51	-1,085.59	-205.99	-13,719.26
EBITDA	- -	-2	-3	-2	-1	- -	-2	-4	-3	-6	-11	-19	-11	-12	-14
EBITDA-CapEx	- -	-2	-3	-2	-1	- -	-2	-4	-3	-6	-11	-19	-11	-12	-15
Operating Income (Loss)	- -	-2	-3	-2	-1	- -	-2	-5	-4	-6	-12	-20	-11	-12	-14

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	8.45	1.43	0.17	- -	- -	0.43	1.1	2.7	0.58	12.63	16.99	6.51	6.44	0.78	2.48
Current Ratio	8.48	1.62	0.46	0.45	0.05	- -	1.14	3.13	0.85	13.27	18.87	8.4	7.71	1.23	2.54
Quick Ratio	8.48	1.47	0.18	- -	- -	0.43	1.12	2.73	0.58	12.82	17.06	6.51	6.44	0.78	2.48
CFO/Avg Current Liab	- -	-3.62	-2.76	-2.74	-0.6	-0.02	-0.67	-2.28	-2.99	-2.61	-7.95	-9.75	-9.33	-9.94	-6.04
Common Equity/Total Assets	52.3	65.96	56.87	47.45	-1,896.86	-72,634.35	12.51	77.73	73.62	90.98	96.3	86.67	86.22	52.52	71.38
Long-Term Debt/Equity (%)	79.28	23.66	8.71	40.9	- -	- -	- -	- -	1.84	0.54	0.03	2.02	1.34	0.03	- -
Long-Term Debt/Capital (%)	41.71	16.4	5.94	27.78	- -	- -	- -	- -	1.63	0.53	0.03	1.96	1.3	0.03	- -
Long-Term Debt/Total Assets (%)	41.47	15.61	4.95	19.41	- -	- -	- -	- -	1.35	0.49	0.03	1.75	1.16	0.02	- -
Total Debt/Equity (%)	90.09	44.23	46.48	47.23	-69.05	-68.58	656.16	2.37	12.83	1.43	0.31	3.07	3.02	4.33	- -
Total Debt/Capital (%)	47.39	30.67	31.73	32.08	-223.12	-218.23	86.78	2.32	11.37	1.41	0.31	2.98	2.93	4.15	- -
Total Debt/Total Assets (%)	47.12	29.18	26.43	22.41	1,309.8	49,809.73	82.09	1.84	9.44	1.3	0.3	2.66	2.6	2.28	- -
CFO/Total Liabilities	- -	-143.17	-200.35	-201.18	-41.86	-1.83	-63.4	-133.38	-95.8	-138.17	-890.97	-835.88	-1,011.1	-733.48	-509.12
CFO/CapEx	- -	-5.66	-91.74	-244.54	-623.24	- -	-80.24	-166.41	- -	- -	- -	- -	-2,904.66	-3,466.41	-13.39
Altman's Z-Score	0.59	-7.86	-22.3	-26.89	-252.34	-7,540.62	32.01	18.32	-2.4	22.31	43.46	-7.95	-17.28	-48.72	-21.45

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	9.62	12.59	10.46	173.17	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	37.95	29	34.9	2.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	5.47	1.36	0.3	1.15	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	66.76	268.9	1,221.87	317.81	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	4.97	4.89	0.5	-0.6	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	73.37	74.59	729.49	-612.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	31.34	223.31	527.28	932.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	-28.82	-239.9	-1,186.97	-315.7	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	3	1	- -	155	139	99	94	77	18	9	3	7
- Cash & Cash Equivalents	3	1	- -	- -	- -	- -	3	2	1	15	16	7	5	1	6
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	1	1	1	1	2	2	- -	1	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	1	4	2	1	155	138	99	78	61	11	4	2	2
Total Capital	5	4	2	2	-1	-1	3	10	9	23	26	8	5	2	6
Total Debt/Capital (%)	47.39	30.67	31.73	32.08	-223.12	-218.23	86.78	2.32	11.37	1.41	0.31	2.98	2.93	4.15	- -
Total Debt / EV	-8.48	10.1	1.32	0.14	0.69	1.64	0.02	- -	0.01	- -	- -	0.02	0.04	0.03	- -
EV/Sales	- -	0.58	1.89	37.42	17.57	196.54	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	4.86	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	4.86	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	3	1	- -	143	134	99	49	75	1	9	3	4
Diluted Enterprise Value	- -	- -	1	4	2	2	143	133	100	34	59	-5	4	2	-2
EV per Share	- -	340.99	1,792.95	8,976.44	4,438.58	2,188.65	15,360.42	12,463.25	9,030.66	2,765.76	1,927.43	354.36	78.69	14.55	0.73
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	-2	-3	-2	-1	- -	-2	-4	-3	-6	-11	-19	-11	-12	-14
TTM Operating Income	- -	-2	-3	-2	-1	- -	-2	-5	-4	-6	-12	-20	-11	-12	-14
TTM Cash Flow to Firm	- -	-2	-2	-2	-1	- -	-2	-4	-3	-3	-9	-10	-8	-11	-11
TTM Free Cash Flow to Firm	- -	-1	-2	-2	-1	- -	-2	-4	-3	-3	-9	-10	-8	-11	-11

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-1.28	-0.72	-9.09	-87.77	-36.46	-36.17	-15.74	-8.61	-0.09	-1.09	-0.24	-0.36
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	1	4	2	1	155	138	99	78	61	11	4	2	2
Low Price	- -	- -	- -	4,130	525	525	490	5,250	4,690	1,700	1,927.5	505	90	20.3	2.74
EV/Sales	- -	0.58	1.89	37.42	17.57	196.54	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-0.56	-0.52	-1.23	-7	-36.29	-28.61	-4.38	-10.05	-0.08	-1.31	-0.5	-0.81
Price/Earnings High	- -	- -	- -	-0.71	-1.02	-1.66	-77.26	-50.81	-42.04	-9.37	-19.09	-0.15	-3.42	-1.91	-2.61
Price/Earnings Low	- -	- -	- -	-0.31	-0.07	-0.62	-2.46	-14.87	-15.44	-1.77	-5.17	-0.03	-0.42	-0.21	-0.26
Price/Book Value	- -	- -	- -	2.85	-0.32	-0.17	415.86	14.35	12.32	4.08	3.02	2.36	1.72	1.93	1.33
Price/Book Value Average	- -	- -	- -	2.8	-0.89	-0.2	37.67	14.59	11.9	5.21	4.62	6.12	2.86	4.24	3.88
Price/Book Value High	- -	- -	- -	3.56	-1.75	-0.27	415.86	20.43	17.49	11.13	8.78	11.29	7.48	16.15	12.45
Price/Book Value Low	- -	- -	- -	1.53	-0.12	-0.1	13.23	5.98	6.42	2.1	2.38	2.17	0.93	1.77	1.26
Price/Tangible Book Value	- -	- -	- -	-7.05	-0.32	-0.17	415.86	-188.96	-60.59	6.64	4.42	2.36	1.72	1.93	1.33
Price/Tangible Book Value Average	- -	- -	- -	-6.92	-0.89	-0.2	37.67	-192.15	-58.51	8.48	6.76	6.12	2.86	4.24	3.88
Price/Tangible Book Value High	- -	- -	- -	-8.81	-1.75	-0.27	415.86	-269	-86	18.12	12.84	11.29	7.48	16.15	12.45
Price/Tangible Book Value Low	- -	- -	- -	-3.78	-0.12	-0.1	13.23	-78.73	-31.57	3.42	3.47	2.17	0.93	1.77	1.26
Price/Sales	- -	- -	- -	32.1	5.54	78.58	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	31.54	15.56	93.24	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	40.12	30.48	125.72	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	17.21	2.08	47.14	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-1.28	-0.72	-9.09	-86.68	-36.24	-36.17	-15.74	-8.61	-0.09	-1.09	-0.24	-0.33
Price/Cash Flow Average	- -	- -	- -	-1.26	-2.02	-10.79	-7.85	-36.85	-34.93	-20.09	-13.18	-0.24	-1.8	-0.53	-0.97
Price/Cash Flow High	- -	- -	- -	-1.6	-3.97	-14.55	-86.68	-51.59	-51.33	-42.95	-25.02	-0.44	-4.72	-2.01	-3.1
Price/Cash Flow Low	- -	- -	- -	-0.69	-0.27	-5.46	-2.76	-15.1	-18.85	-8.11	-6.77	-0.08	-0.59	-0.22	-0.32
Price/Free Cash Flow Average	- -	- -	- -	-1.26	-2.03	-10.79	-7.95	-37.07	-34.93	-20.09	-13.18	-0.24	-1.8	-0.53	-1.05
Price/Free Cash Flow High	- -	- -	- -	-1.6	-3.97	-14.55	-87.77	-51.9	-51.33	-42.95	-25.02	-0.44	-4.72	-2.01	-3.36
Price/Free Cash Flow Low	- -	- -	- -	-0.69	-0.27	-5.46	-2.79	-15.19	-18.85	-8.11	-6.77	-0.08	-0.59	-0.22	-0.34
EV/Sales Average	- -	0.58	1.89	36.86	27.59	415.07	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	0.58	1.89	45.44	42.51	447.54	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	0.58	1.89	22.54	14.11	368.97	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	- -	-0.05	-0.23	-2.29	-4.18	-29.08	-7.59	-35.96	-30.56	-18.53	-9.41	-2.03	-0.85	-0.5	-1.15
EV/EBITDA High	- -	-0.05	-0.23	-2.82	-6.44	-31.36	-85.97	-50.5	-44.86	-42.66	-19.24	-4.01	-2.86	-2.18	-4.57
EV/EBITDA Low	- -	-0.05	-0.23	-1.4	-2.14	-25.85	-2.52	-14.51	-16.54	-5.88	-4.1	-0.51	-0.01	-0.16	-0.11
EV/EBIT Average	- -	-0.05	-0.2	-1.83	-3.17	-29.02	-7.58	-30.95	-24.32	-16.21	-8.76	-1.95	-0.85	-0.5	-1.15
EV/EBIT High	- -	-0.05	-0.2	-2.26	-4.88	-31.29	-85.88	-43.47	-35.7	-37.33	-17.92	-3.85	-2.86	-2.18	-4.57
EV/EBIT Low	- -	-0.05	-0.2	-1.12	-1.62	-25.79	-2.52	-12.49	-13.16	-5.15	-3.82	-0.49	-0.01	-0.16	-0.11
Last Price	- -	- -	- -	7,700	1,400	875	15,400	12,600	9,000	3,297.5	2,450	550	167.25	22.1	2.88
High Price	- -	- -	- -	9,625	7,700	1,400	15,400	17,937.5	12,775	9,000	7,120	2,630	725	185	27
Enterprise Value Average	- -	- -	1	4	3	2	14	140	96	104	101	39	10	6	16
Enterprise Value High	- -	- -	1	5	5	2	155	197	141	240	207	78	33	26	64
Enterprise Value Low	- -	- -	1	2	2	2	5	56	52	33	44	10	- -	2	2

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Revenue per Share	- -	584.03	949.79	239.91	252.62	11.14	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	-6,578.44	-7,739.86	-3,868.72	-1,666.67	-158.95	-193.34	-365.23	-283.39	-375.56	-351.72	-12,092.42	-218.38	-98.42	-10.68
Operating Income per Share	- -	-6,908.12	-9,000.97	-4,826.6	-2,198.57	-159.3	-193.54	-424.32	-356.12	-429.15	-377.54	-12,582.17	-218.39	-98.43	-10.68
Basic EPS, GAAP	- -	-8,418.57	-9,392.11	-13,488.01	-7,566.08	-844.19	-199.33	-353.06	-303.85	-960.98	-372.99	-17,033.68	-211.99	-96.78	-10.36
Basic EPS from Cont Ops	- -	-7,418.05	-9,327.36	-8,245.19	-6,643.47	-750.96	-199.33	-353.06	-303.85	-960.98	-372.99	-17,033.68	-211.99	-96.78	-10.36
Diluted EPS, GAAP	- -	-8,418.57	-9,392.11	-13,488.01	-7,566.08	-844.19	-199.33	-353.06	-303.85	-960.98	-372.99	-17,033.68	-211.99	-96.78	-10.36
Diluted EPS from Cont Ops	- -	-7,418.05	-9,327.36	-8,245.19	-6,643.47	-750.96	-199.33	-353.06	-303.85	-960.98	-372.99	-17,033.68	-211.99	-96.78	-10.36
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-5,752.28	-7,716.62	-6,021.56	-1,941.88	-96.22	-177.67	-347.7	-248.86	-209.56	-284.53	-5,965.93	-153.7	-91.84	-8.7
Free Cash Flow per Basic Share	- -	-6,768.5	-7,800.74	-6,046.19	-1,945	-96.22	-179.88	-349.79	-248.86	-209.56	-284.53	-5,965.93	-153.75	-91.87	-9.35
Cash & Equivalents per Share	8,495.25	3,104.79	567.98	- -	4.65	2,277.35	282.57	157.57	63.03	543.3	525.07	202.79	91.49	8.04	2.15
Book Value per Share	8,434.06	7,787.29	5,078.35	2,702.27	-4,407.18	-5,236.47	37.03	878	730.27	808.44	811.11	232.95	96.99	11.45	2.17
Tangible Book Value per Share	835.28	459.89	-1,163.51	-1,092.87	-4,407.18	-5,236.47	37.03	-66.68	-148.55	496.65	554.69	232.95	96.99	11.45	2.17

Processa Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)